The role of FoxC2 transcription factor in tumor angiogenesis

Journal of Oncology

Volumn , Issue , 2012, Pages

  Kume, Tsutomu ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA3 INTEGRIN; CHEMOKINE RECEPTOR CXCR4; FORKHEAD TRANSCRIPTION FACTOR; NOTCH1 RECEPTOR; SIRTUIN 1; STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTION FACTOR FOXC2; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; BREAST CANCER; CANCER CELL; CANCER SURVIVAL; CANCER THERAPY; COLON CANCER; DISEASE COURSE; ESOPHAGUS CANCER; HUMAN; MELANOMA; NONHUMAN; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TUMOR ANGIOGENESIS;

EID: 84855606292     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2012/204593     Document Type: Review

References (72)

1. Hanahan D., Weinberg R. A., The hallmarks of cancer Cell 2000 100 1 57 70 (Pubitemid 30046295)
2. Carmeliet P., Angiogenesis in life, disease and medicine Nature 2005 438 7070 932 936 (Pubitemid 43093958)
3. Ferrara N., Kerbel R. S., Angiogenesis as a therapeutic target Nature 2005 438 7070 967 974 (Pubitemid 43093963)
4. McDonald D. M., Choyke P. L., Imaging of angiogenesis: from microscope to clinic Nature Medicine 2003 9 6 713 725 (Pubitemid 36749220)
5. Kaestner K. H., Knchel W., Martnez D. E., Unified nomenclature for the winged helix/forkhead transcription factors Genes and Development 2000 14 2 142 146 (Pubitemid 30070978)
6. Shimeld S. M., Degnan B., Luke G. N., Evolutionary genomics of the Fox genes: origin of gene families and the ancestry of gene clusters Genomics 2010 95 5 256 260
7. Wotton K. R., Shimeld S. M., Comparative genomics of vertebrate Fox cluster loci BMC Genomics 2006 7, article 271
8. Carlsson P., Mahlapuu M., Forkhead transcription factors: key players in development and metabolism Developmental Biology 2002 250 1 1 23
9. Kaufmann E., Knchel W., Five years on the wings of fork head Mechanisms of Development 1996 57 1 3 20 (Pubitemid 26197454)
10. Myatt S. S., Lam E. W., The emerging roles of forkhead box (Fox) proteins in cancer Nature Reviews Cancer 2007 7 11 847 859 (Pubitemid 350006253)
11. Wang Z., Banerjee S., Kong D., Li Y., Sarkar F. H., Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells Cancer Research 2007 67 17 8293 8300 (Pubitemid 47395167)
12. Zhang Y., Zhang N., Dai B., Liu M., Sawaya R., Xie K., Huang S., FoxM1B transcriptionally regulates vascular endothelial growth factor expression and promotes the angiogenesis and growth of glioma cells Cancer Research 2008 68 21 8733 8742
13. Dong X. Y., Chen C., Sun X., Guo P., Vessella R. L., Wang R. X., Chung L. W. K., Zhou W., Dong J. T., FOXO1A is a candidate for the 13q14 tumor suppressor gene inhibiting androgen receptor signaling in prostate cancer Cancer Research 2006 66 14 6998 7006 (Pubitemid 44197675)
14. Paik J. H., Kollipara R., Chu G., Ji H., Xiao Y., Ding Z., Miao L., Tothova Z., Horner J. W., Carrasco D. R., Jiang S., Gilliland D. G., Chin L., Wong W. H., Castrillon D. H., DePinho R. A., FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis Cell 2007 128 2 309 323 (Pubitemid 46123514)
15. Sano H., LeBoeuf J. P., Novitskiy S. V., Seo S., Zaja-Milatovic S., Dikov M. M., Kume T., The FoxC2 transcription factor regulates tumor angiogenesis Biochemical and Biophysical Research Communications 2010 392 2 201 206
16. Iida K., Koseki H., Kakinuma H., Kato N., Mizutani-Koseki Y., Ohuchi H., Yoshioka H., Noji S., Kawamura K., Kataoka Y., Ueno F., Taniguchi M., Yoshida N., Sugiyama T., Miura N., Essential roles of the winged helix transcription factor MFH-1 in aortic arch patterning and skeletogenesis Development 1997 124 22 4627 4638 (Pubitemid 27519257)
17. Kume T., Jiang H., Topczewska J. M., Hogan B. L., The murine winged helix transcription factors, Foxc1 and FoxC2, are both required for cardiovascular development and somitogenesis Genes and Development 2001 15 18 2470 2482 (Pubitemid 32899749)
18. Seo S., Fujita H., Nakano A., Kang M., Duarte A., Kume T., The forkhead transcription factors, Foxc1 and FoxC2, are required for arterial specification and lymphatic sprouting during vascular development Developmental Biology 2006 294 2 458 470 (Pubitemid 43884821)
19. Winnier G. E., Kume T., Deng K., Rogers R., Bundy J., Raines C., Walter M. A., Hogan B. L. M., Conway S. J., Roles for the winged helix transcription factors MF1 and MFH1 in cardiovascular development revealed by nonallelic noncomplementation of null alleles Developmental Biology 1999 213 2 418 431 (Pubitemid 29444350)
20. Hayashi H., Kume T., Foxc transcription factors directly regulate DII4 and hey2 expression by interacting with the VEGF-notch signaling pathways in endothelial cells PLoS ONE 2008 3 6
21. Kume T., The cooperative roles of Foxc1 and FoxC2 in cardiovascular development Advances in Experimental Medicine and Biology 2009 665 63 77
22. Papanicolaou K. N., Izumiya Y., Walsh K., Forkhead transcription factors and cardiovascular biology Circulation Research 2008 102 1 16 31
23. Hayashi H., Kume T., FoxC2 transcription factor as a regulator of angiogenesis via induction of integrin 3 expression Cell Adhesion and Migration 2009 3 1 24 26
24. Kume T., FoxC2 transcription factor: a newly described regulator of angiogenesis Trends in Cardiovascular Medicine 2008 18 6 224 228
25. Hayashi H., Kume T., Forkhead transcription factors regulate expression of the chemokine receptor CXCR4 in endothelial cells and CXCL12-induced cell migration Biochemical and Biophysical Research Communications 2008 367 3 584 589
26. Hayashi H., Sano H., Seo S., Kume T., The FoxC2 transcription factor regulates angiogenesis via induction of integrin 3 expression Journal of Biological Chemistry 2008 283 35 23791 23800
27. de Val S., Chi N. C., Meadows S. M., Minovitsky S., Anderson J. P., Harris I. S., Ehlers M. L., Agarwal P., Visel A., Xu S. M., Pennacchio L. A., Dubchak I., Krieg P. A., Stainier D. Y. R., Black B. L., Combinatorial regulation of endothelial gene expression by ets and forkhead transcription factors Cell 2008 135 6 1053 1064
28. Oettgen P., The role of ets factors in tumor angiogenesis Journal of Oncology 2010 2010 6
29. Buysschaert I., Schmidt T., Roncal C., Carmeliet P., Lambrechts D., Genetics, epigenetics and pharmaco-(epi)genomics Journal of Cellular and Molecular Medicine 2008 12 6B 2533 2551
30. Potente M., Ghaeni L., Baldessari D., Mostoslavsky R., Rossig L., Dequiedt F., Haendeler J., Mione M., Dejana E., Alt F. W., Zeiher A. M., Dimmeler S., SIRT1 controls endothelial angiogenic functions during vascular growth Genes and Development 2007 21 20 2644 2658 (Pubitemid 47607673)
31. Guarani V., Deflorian G., Franco C. A., Krger M., Phng L. -K., Bentley K., Toussaint L., Dequiedt F., Mostoslavsky R., Schmidt M. H.H., Zimmermann B., Brandes R. P., Mione M., Westphal C. H., Braun T., Zeiher A. M., Gerhardt H., Dimmeler S., Potente M., Acetylation-dependent regulation of endothelial Notch signalling by the SIRT1 deacetylase Nature 2011 473 7346 234 238
32. Dagenais S. L., Hartsough R. L., Erickson R. P., Witte M. H., Butler M. G., Glover T. W., FoxC2 is expressed in developing lymphatic vessels and other tissues associated with lymphedema-distichiasis syndrome Gene Expression Patterns 2004 4 6 611 619 (Pubitemid 39307524)
33. Petrova T. V., Karpanen T., Norrmén C., Mellor R., Tamakoshi T., Finegold D., Ferrell R., Kerjaschki D., Mortimer P., Yl-Herttuala S., Miura N., Alitalo K., Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis Nature Medicine 2004 10 9 974 981 (Pubitemid 39273739)
34. Fang J., Dagenais S. L., Erickson R. P., Arlt M. F., Glynn M. W., Gorski J. L., Seaver L. H., Glover T. W., Mutations in FoxC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema- distichiasis syndrome American Journal of Human Genetics 2000 67 6 1382 1388
35. Mkinen T., Norrmén C., Petrova T. V., Molecular mechanisms of lymphatic vascular development Cellular and Molecular Life Sciences 2007 64 15 1915 1929 (Pubitemid 47094431)
36. Kriederman B. M., Myloyde T. L., Witte M. H., Dagenais S. L., Witte C. L., Rennels M., Bernas M. J., Lynch M. T., Erickson R. P., Caulder M. S., Miura N., Jackson D., Brooks B. P., Glover T. W., FoxC2 haploinsufficient mice are a model for human autosomal dominant lymphedema-distichiasis syndrome Human Molecular Genetics 2003 12 10 1179 1185 (Pubitemid 36622150)
37. Itoh T., Tanioka M., Yoshida H., Yoshioka T., Nishimoto H., Itohara S., Reduced angiogenesis and tumor progression in gelatinase A-deficient mice Cancer Research 1998 58 5 1048 1051 (Pubitemid 28182477)
38. Taniwaki K., Fukamachi H., Komori K., Ohtake Y., Nonaka T., Sakamoto T., Shiomi T., Okada Y., Itoh T., Itohara S., Seiki M., Yana I., Stroma-derived matrix metalloproteinase (MMP)-2 promotes membrane type 1-MMP-dependent tumor growth in mice Cancer Research 2007 67 9 4311 4319 (Pubitemid 46815079)
39. Nishida N., Mimori K., Yokobori T., Sudo T., Tanaka F., Shibata K., Ishii H., Doki Y., Mori M., FoxC2 is a novel prognostic factor in human esophageal squamous cell carcinoma Annals of Surgical Oncology 2010 1 8
40. Mani S. A., Yang J., Brooks M., Schwaninger G., Zhou A., Miura N., Kutok J. L., Hartwell K., Richardson A. L., Weinberg R. A., Mesenchyme Forkhead 1 (FoxC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers Proceedings of the National Academy of Sciences of the United States of America 2007 104 24 10069 10074 (Pubitemid 47175264)
41. Mani S. A., Guo W., Liao M. J., Eaton E. N., Ayyanan A., Zhou A. Y., Brooks M., Reinhard F., Zhang C. C., Shipitsin M., Campbell L. L., Polyak K., Brisken C., Yang J., Weinberg R. A., The epithelial-mesenchymal transition generates cells with properties of stem cells Cell 2008 133 4 704 715 (Pubitemid 351636299)
42. Lee S., Chen T. T., Barber C. L., Jordan M. C., Murdock J., Desai S., Ferrara N., Nagy A., Roos K. P., Iruela-Arispe M. L., Autocrine VEGF signaling is required for vascular homeostasis Cell 2007 130 4 691 703 (Pubitemid 47268059)
43. Ferrara N., Pathways mediating VEGF-independent tumor angiogenesis Cytokine and Growth Factor Reviews 2010 21 1 21 26
44. Fukumura D., Xavier R., Sugiura T., Chen Y., Park E. C., Lu N., Selig M., Nielsen G., Taksir T., Jain R. K., Seed B., Tumor induction of VEGF promoter activity in stromal cells Cell 1998 94 6 715 725 (Pubitemid 28436004)
45. Orimo A., Gupta P. B., Sgroi D. C., Arenzana-Seisdedos F., Delaunay T., Naeem R., Carey V. J., Richardson A. L., Weinberg R. A., Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion Cell 2005 121 3 335 348 (Pubitemid 40692295)
46. Li D., Yan D., Liu W., Li M., Yu J., Li Y., Qu Z., Ruan Q., FoxC2 overexpression enhances benefit of endothelial progenitor cells for inhibiting neointimal formation by promoting CXCR4-dependent homing Journal of Vascular Surgery 2011 53 6 1668 1678
47. Hader C., Marlier A., Cantley L., Mesenchymal-epithelial transition in epithelial response to injury: the role of FoxC2 Oncogene 2010 29 7 1031 1040
48. Burger J. A., Kipps T. J., CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment Blood 2006 107 5 1761 1767 (Pubitemid 43289351)
49. Lin Q., Yun Z., Impact of the hypoxic tumor microenvironment on the regulation of cancer stem cell characteristics Cancer Biology and Therapy 2010 9 12 949 956
50. Sugimoto H., Mundel T. M., Kieran M. W., Kalluri R., Identification of fibroblast heterogeneity in the tumor microenvironment Cancer Biology and Therapy 2006 5 12 1640 1646
51. Zeisberg E. M., Potenta S., Xie L., Zeisberg M., Kalluri R., Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts Cancer Research 2007 67 21 10123 10128 (Pubitemid 350070783)
52. Kalluri R., Zeisberg M., Fibroblasts in cancer Nature Reviews Cancer 2006 6 5 392 401
53. Xouri G., Christian S., Origin and function of tumor stroma fibroblasts Seminars in Cell and Developmental Biology 2010 21 1 40 46
54. Andrae J., Gallini R., Betsholtz C., Role of platelet-derived growth factors in physiology and medicine Genes and Development 2008 22 10 1276 1312 (Pubitemid 351717519)
55. Sennino B., Falcn B. L., McCauley D., Le T., McCauley T., Kurz J. C., Haskell A., Epstein D. M., M D. M., Sequential loss of tumor vessel pericytes and endothelial cells after inhibition of platelet-derived growth factor B by selective aptamer AX102 Cancer Research 2007 67 15 7358 7367 (Pubitemid 47206566)
56. Erber R., Thurnher A., Katsen A. D., Groth G., Kerger H., Hammes H. P., Menger M. D., Ullrich A., Vajkoczy P., Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms The FASEB Journal 2004 18 2 338 340
57. Potapova O., Laird A. D., Nannini M. A., Barone A., Li G., Moss K. G., Cherrington J. M., Mendel D. B., Contribution of individual targets to the antitumor efficacy of the multitargeted receptor tyrosine kinase inhibitor SU11248 Molecular Cancer Therapeutics 2006 5 5 1280 1289 (Pubitemid 43881321)
58. Guo P., Hu B., Gu W., Xu L., Wang D., Huang H. J. S., Cavenee W. K., Cheng S. Y., Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment American Journal of Pathology 2003 162 4 1083 1093 (Pubitemid 36350654)
59. Yang J., Weinberg R. A., Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis Developmental Cell 2008 14 6 818 829 (Pubitemid 351757205)
60. Lindley L. E., Briegel K. J., Molecular characterization of TGFbeta-induced epithelial-mesenchymal transition in normal finite lifespan human mammary epithelial cells Biochemical and Biophysical Research Communications 2010 399 4 659 664
61. Mortazavi F., An J., Dubinett S., Rettig M., p120-Catenin is transcriptionally downregulated by FoxC2 in non-small cell lung cancer cells Molecular Cancer Research 2010 8 5 762 774
62. Thiery J. P., Acloque H., Huang R. Y. J., Nieto M. A., Epithelial-mesenchymal transitions in development and disease Cell 2009 139 5 871 890
63. Garraway L. A., Sellers W. R., Lineage dependency and lineage-survival oncogenes in human cancer Nature Reviews Cancer 2006 6 8 593 602 (Pubitemid 44140858)
64. Gupta P. B., Kuperwasser C., Brunet J. P., Ramaswamy S., Kuo W. L., Gray J. W., Naber S. P., Weinberg R. A., The melanocyte differentiation program predisposes to metastasis after neoplastic transformation Nature Genetics 2005 37 10 1047 1054 (Pubitemid 41486656)
65. Johnston R. N., Pai S. B., Pai R. B., The origin of the cancer cell: oncogeny reverses phylogeny Biochemistry and Cell Biology 1992 70 10-11 831 834
66. Wang Z., Ahmad A., Li Y., Banerjee S., Kong D., Sarkar F. H., Forkhead box M1 transcription factor: a novel target for cancer therapy Cancer Treatment Reviews 2010 36 2 151 156
67. Bhat U. G., Halasi M., Gartel A. L., FoxM1 is a general target for proteasome inhibitors PLoS ONE 2009 4 8
68. Bhat U. G., Halasi M., Gartel A. L., Thiazole antibiotics target FoxM1 and induce apoptosis in human cancer cells PLoS ONE 2009 4 5
69. Li Y., Hong X., Hussain M., Sarkar S. H., Li R., Sarkar F. H., Gene expression profiling revealed novel molecular targets of docetaxel and estramustine combination treatment in prostate cancer cells Molecular Cancer Therapeutics 2005 4 3 389 398 (Pubitemid 40443924)
70. Li Y., Hussain M., Sarkar S. H., Eliason J., Li R., Sarkar F. H., Gene expression profiling revealed novel mechanism of action of Taxotere and Furtulon in prostate cancer cells BMC Cancer 2005 5, article 7
71. Radhakrishnan S. K., Bhat U. G., Hughes D. E., Wang I. C., Costa R. H., Gartel A. L., Identification of a chemical inhibitor of the oncogenic transcription factor forkhead box M1 Cancer Research 2006 66 19 9731 9735 (Pubitemid 44623674)
72. Gusarova G. A., Wang I. C., Major M. L., Kalinichenko V. V., Ackerson T., Petrovic V., Costa R. H., A cell-penetrating ARF peptide inhibitor of FoxM1 in mouse hepatocellular carcinoma treatment Journal of Clinical Investigation 2007 117 1 99 111 (Pubitemid 46048457)